Deutsche Bank’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-81,083
| Closed | -$299K | – | 5159 |
|
|
2017
Q4 | $299K | Sell |
81,083
-244,491
| -75% | -$902K | ﹤0.01% | 3711 |
|
|
2017
Q3 | $1.33M | Sell |
325,574
-7,754
| -2% | -$31.7K | ﹤0.01% | 2774 |
|
|
2017
Q2 | $1.24M | Buy |
333,328
+39,541
| +13% | +$147K | ﹤0.01% | 2838 |
|
|
2017
Q1 | $1.22M | Buy |
293,787
+79,100
| +37% | +$327K | ﹤0.01% | 2498 |
|
|
2016
Q4 | $925K | Buy |
214,687
+34,197
| +19% | +$147K | ﹤0.01% | 2709 |
|
|
2016
Q3 | $1.78M | Buy |
180,490
+16,585
| +10% | +$163K | ﹤0.01% | 2414 |
|
|
2016
Q2 | $925K | Buy |
163,905
+69,011
| +73% | +$389K | ﹤0.01% | 2909 |
|
|
2016
Q1 | $720K | Buy |
94,894
+18,309
| +24% | +$139K | ﹤0.01% | 2968 |
|
|
2015
Q4 | $1.02M | Sell |
76,585
-15,394
| -17% | -$205K | ﹤0.01% | 2817 |
|
|
2015
Q3 | $1.51M | Buy |
91,979
+3,181
| +4% | +$52.2K | ﹤0.01% | 2642 |
|
|
2015
Q2 | $1.99M | Buy |
88,798
+7,230
| +9% | +$162K | ﹤0.01% | 2437 |
|
|
2015
Q1 | $796K | Buy |
81,568
+52,721
| +183% | +$514K | ﹤0.01% | 2960 |
|
|
2014
Q4 | $328K | Buy |
28,847
+28,733
| +25,204% | +$327K | ﹤0.01% | 3827 |
|
|
2014
Q3 | $1K | Sell |
114
-51,305
| -100% | -$450K | ﹤0.01% | 5147 |
|
|
2014
Q2 | $998K | Sell |
51,419
-7,717
| -13% | -$150K | ﹤0.01% | 2890 |
|
|
2014
Q1 | $1.06M | Sell |
59,136
-24,564
| -29% | -$440K | ﹤0.01% | 2824 |
|
|
2013
Q4 | $883K | Sell |
83,700
-10,238
| -11% | -$108K | ﹤0.01% | 2737 |
|
|
2013
Q3 | $1.16M | Sell |
93,938
-40,836
| -30% | -$504K | ﹤0.01% | 2860 |
|
|
2013
Q2 | $1.27M | Buy |
+134,774
| New | +$1.27M | ﹤0.01% | 2527 |
|